Paper Review Records
全部论文审稿周期
22 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
206
天
Beyond borders: advancing oncology trials
作者
Milit S. Patel; Jeffrey Shi Kai Chan; Nina N. Sanford; Jonas Willmann; Puneeth Iyengar; Edward Christopher Dee展开收起
作者单位
1. Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA; 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; 3. Cardio-Oncology Research Unit, Cardiovascular Analytics Group, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, China; 4. Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, USA; 5. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; 6. Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland展开收起
144
天
Multi-scale transcriptomic integration reveals LINC00152-high tumor cells promote TGCT progression and T cell exhaustion
作者
Jian Cao; Fang Zhu; Kongrong Xu; Zhizhong Liu; Lei Chen; Shanshan Lv; Liqing Fan; Jie Guo; Mina Tao; Yanwei Luo; Guoli Li; Hao Bo展开收起
作者单位
1. Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China; 2. NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China; 3. Department of Reproductive Medicine, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; 4. Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, China; 5. Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China; 6. National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China; 7. Department of Nephrology, Hunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China; 8. Hunan Engineering Research Center for Prevention, Treatment and Rehabilitation of Kidney Diseases, Changsha, China; 9. Changsha Innovation Center for Integrated Diagnosis and Treatment Technology of Metabolic dysfunction–associated kidney diseases, Changsha, China展开收起
163
天
Primary tumour resection in de novo stage IV breast cancer: considerations from the PRIM-BC trial
作者
Ahmad Kaviani; Neda Karkeabadi; Borna Farazmand展开收起
作者单位
1. Centre hospitalier de l’Université de Montréal, Department of Surgery- Surgical Oncology Service, Montreal, Canada; 2. Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 4. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran展开收起
184
天
The brain-lung immunotherapy prognostic (BLIP) Score: a novel robust tool for prognostication in non-small cell lung cancer patients with brain metastases
作者
Marcus Skribek; Maria-Effrosyni Livanou; Ioannis Vathiotis; Viktor Strandman; Axel Thorell; Andreas Koulouris; Konstantinos Syrigos; Simon Ekman; Georgios Tsakonas展开收起
作者单位
1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; 3. Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece; 4. Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, Greece展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天